Cargando…
Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention
OBJECTIVES: Trimetazidine is an anti-ischemic medication licensed for the treatment of angina pectoris. However, the molecular mechanisms underlying its action remain incompletely elucidated. In this study, therefore, we examined the potential beneficial effects of trimetazidine on myocardial injury...
Autores principales: | Shao, Shuai, Shi, Zhaozhao, Tse, Gary, Wang, Xinghua, Ni, Yanping, Liu, Hongmei, Liu, Tong, Li, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745110/ https://www.ncbi.nlm.nih.gov/pubmed/31565429 http://dx.doi.org/10.1155/2019/4230948 |
Ejemplares similares
-
Effects of nicorandil infusion on ECG parameters in patients with unstable angina pectoris and percutaneous coronary intervention
por: Wang, Weiding, et al.
Publicado: (2019) -
Effects of trimetazidine on periprocedural microRNA-21 expression by CD4+ T lymphocytes in patients with unstable angina pectoris
por: Su, Qiang, et al.
Publicado: (2017) -
Compound danshen dripping pills combined with trimetazidine in treating unstable angina pectoris: Protocol for a systematic review of randomized controlled trials
por: Yao, Dongfeng, et al.
Publicado: (2019) -
Economic evaluation of trimetazidine in the management of chronic stable angina in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016) -
Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
por: Tang, Xiuying, et al.
Publicado: (2022)